phenyl acetate has been researched along with Weight Reduction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, EL; Billmeier, S; Chinburg, EL; Gilbert-Diamond, D; McClure, AC; Meijer, JL; Renier, TJ; Roderka, MN; Rothstein, RI | 1 |
| Argo, CM; Barfoot, C; Dugdale, AH; Grove-White, DH; Harris, PA; Jones, E; Morrison, PK; Newbold, CJ; Worgan, HJ | 1 |
| Al-Shurbaji, A; Denison, H; Eriksson, JW; Himmelmann, A; Knutsson, M; Löfgren, L; Mårtensson, G; Nilsson, C; Tornqvist, H | 1 |
| Alkhader, M; Gouma, PI; Stanaćević, M | 1 |
| Garcia, RA; Hu, Z; Li, D; Liu, LS; Saydoff, JA; von Borstel, RW | 1 |
| Kimura, K; Matsushita, Y; Omachi, A; Saito, M | 1 |
| Fox, SD; Henderson, LW | 1 |
| DeCerce, J; DeToledo, JC; Ramsay, RE; Toledo, C | 1 |
3 trial(s) available for phenyl acetate and Weight Reduction
| Article | Year |
|---|---|
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial.
Topics: Acetates; Adult; Anti-Obesity Agents; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Diarrhea; Dose-Response Relationship, Drug; Gastric Emptying; Glucagon-Like Peptide 1; Humans; Intestinal Absorption; Male; Middle Aged; Obesity; Peptide YY; Pyrazines; Treatment Outcome; Weight Loss | 2014 |
Role of uncoupling protein 1 in the anti-obesity effect of beta3-adrenergic agonist in the dog.
Topics: Acetates; Adipocytes; Adrenergic Agonists; Animals; Dog Diseases; Dogs; Drug Administration Schedule; Gene Expression Regulation; Genetic Predisposition to Disease; Indoles; Ion Channels; Male; Mitochondrial Proteins; Obesity; Oxygen Consumption; Uncoupling Protein 1; Weight Loss | 2008 |
Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Topics: Acetates; Acrylic Resins; Acrylonitrile; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Urea Nitrogen; Body Fluids; Body Temperature; Cations; Diabetic Nephropathies; Diabetic Neuropathies; Hemodialysis Solutions; Hemodynamics; Hemofiltration; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis; Weight Loss | 1993 |
5 other study(ies) available for phenyl acetate and Weight Reduction
| Article | Year |
|---|---|
Alterations in Fecal Short-Chain Fatty Acids after Bariatric Surgery: Relationship with Dietary Intake and Weight Loss.
Topics: Acetates; Animals; Bariatric Surgery; Butyrates; Eating; Fatty Acids, Volatile; Gastric Bypass; Hormones; Obesity, Morbid; Propionates; Sugars; Valerates; Weight Loss | 2022 |
The equine gastrointestinal microbiome: impacts of weight-loss.
Topics: Acetates; Animals; Diet; Feces; Female; Gastrointestinal Microbiome; Horses; Obesity; RNA, Ribosomal, 16S; Weight Loss | 2020 |
Metabolic rate monitoring and weight reduction/management.
Topics: Acetates; Acetone; Adipose Tissue; Algorithms; Biomarkers; Breath Tests; Exercise; Exhalation; Health Promotion; Humans; Monitoring, Ambulatory; Obesity; Overweight; Spectroscopy, Fourier Transform Infrared; Weight Loss | 2014 |
Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease.
Topics: Acetates; Administration, Oral; Animals; Huntington Disease; Male; Mice; Mitochondria; Motor Activity; Nerve Degeneration; Nitro Compounds; Prodrugs; Propionates; Uridine; Weight Loss | 2003 |
Changes in body weight with chronic, high-dose gabapentin therapy.
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Body Weight; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Time Factors; Weight Gain; Weight Loss | 1997 |